by Anais MAX | Sep 14, 2021 | News
Two days ago, Biolabs announced the six selected companies for their Masterclass program. SYNSIGHT founders will be participating in the 2021 Masterclass program organized by BioLabs and Servier ! A good chance to meet their team in Boston ! And in addition to being...
by Anais MAX | Sep 14, 2021 | Publications
Identification of a small molecule splicing inhibitor targeting UHM domains Abstract Splicing factor mutations are frequent in myeloid neoplasms, blood cancers and solid tumors. Cancer cells harboring these mutations present a particular vulnerability to drugs that...
by Anais MAX | Sep 7, 2021 | Publications
The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation Abstract TDP-43 is a nuclear RNA-binding protein that forms neuronal cytoplasmic inclusions in two major neurodegenerative diseases, ALS and FTLD. While the self-assembly of TDP-43...
